Skip to main content

Closed

INM: InMed Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-246.8%

ROIC-135.8%

Financially safe

Stretched

Debt / equity0.06×

Interest coverage-496.4×

Current ratio3.11×

InMed Pharmaceuticals Inc.

INMNASDAQ Global Select·USD·Closed

InMed Pharmaceuticals Inc.

INMNASDAQ·USD·Closed

$1.47

−2.00%

$1.47

−$0.03 (2.00%)

52W Range

46thpctl

Volume

0.10×avg

Mkt Cap

2.66MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

46thpctl

Volume

0.10×avg

Market Cap

2.66MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings